Name: Biosensors Market by Type (Sensor Patch, Embedded Device), Product (Wearable, Non-Wearable), Wearable (Wristwear, Bodywear), Technology (Electrochemical, Optical, Piezoelectric, Thermal, Nanomechanical), Application and Region - Global Forecast to 2030
Brand: MarketsandMarkets
SKU: SE3097
Price: 4950 USD
Availability: InStock

報告摘要

The global biosensors market is expected to reach USD 34.51 billion in 2025 from USD 54.37 billion by 2030, growing at a CAGR of 9.5% during this period. Market growth is driven by the rising number of infectious diseases in developing countries, increasing demand for rapid diagnosis and efficient monitoring solutions, and technological advancements such as miniaturization, nanotechnology, microfluidics, and new product innovations. Additionally, the growing demand in urban areas, where diagnostic devices are easily accessible and simple to use, is further boosting market growth. Governments worldwide are launching initiatives to improve diagnostics and drug services, aiming to ensure availability and access to diagnostic testing while reducing patients’ out-of-pocket expenses. “Embedded devices to account for the larger market share in 2030” Embedded devices are commonly used in various applications such as point of care, home diagnostics, food and beverages, research labs, environmental monitoring, and biodefense. With the growth of the Internet of Things (IoT) devices, there has been a significant shift in connected healthcare applications. IoT enables real-time alerts, tracking, and monitoring, which allows for hands-on treatments, improved accuracy, timely interventions by doctors, and overall better patient care. Many healthcare facilities are beginning to adopt embedded solutions for medical devices with IoT capabilities to address the shortage of doctors in remote areas. These IoT-enabled medical devices help identify diseases and perform various tests to deliver accurate and reliable treatment to patients in remote locations. Consequently, the increasing use of embedded devices will boost the market growth of biosensors. “Non-wearable (POC) biosensors to capture the largest share of the biosensors market throughout the forecast period” The non-wearable biosensors market is a vibrant growth area driven by diverse applications, from handheld tools to lab systems and point-of-care diagnostics, vital in healthcare, environmental monitoring, and food safety. These biosensors, used in hospitals, research, food, and environmental sectors, enable real-time, on-site monitoring, helping address food quality challenges and meet safety standards. Market growth is fueled by increased awareness of environmental surveillance and the need for rapid devices for biodefense, food control, and pathogen detection. “China to hold largest share in Asia Pacific of biosensors market in 2030” The factors driving the biosensors market in China include rapid economic growth and an aging population, along with government efforts to improve healthcare services. Many multinational exporters and producers operating in China have adopted strategies such as acquisitions or strategic partnerships that support reliable domestic distribution and service infrastructure. In contrast, many domestic manufacturers, particularly those focused on export markets outside of China, lack strong distribution and service networks within the country. China is the most populous country in the world, and with the one-child policy, the elderly population is expected to increase in the future. As the population ages, there will likely be a significant rise in the incidence of various disorders, including heart diseases. Extensive primary interviews were conducted with key industry experts in the biosensors market to determine and verify the market size for various segments and subsegments gathered through secondary research. The breakdown of primary participants for the report is shown below: The study includes insights from various industry experts, from component suppliers to Tier 1 companies and OEMs. The breakdown of the primary participants is as follows: • By Company Type: Tier 1–40%, Tier 2–35%, and Tier 3–25% • By Designation: C-level Executives–45%, Directors–35%, and Others–20% • By Region: North America–30%, Europe–22%, Asia Pacific–40%, and RoW–8% Abbott Laboratories (US), F. Hoffmann-La Roche Ltd (Switzerland), Medtronic (Ireland), Bio-Rad Laboratories, Inc. (US), DuPont (US), Biosensors International Group, Ltd. (Singapore), Dexcom, Inc. (US), Masimo (US), Nova Biomedical (US), Universal Biosensors (Australia), and ACON Laboratories (US) are some key players in the biosensors market. The study includes an in-depth competitive analysis of these key players in the biosensors market, with their company profiles, recent developments, and key market strategies. Study Coverage: This research report categorizes the biosensors market based on type (sensor patches, embedded devices), product (wearable, non-wearable), technology (electrochemical, optical, piezoelectric, thermal, nanomechanical), component (bioreceptor molecules, biological elements, transducers), application (POC, home diagnostics, research labs, environmental monitoring, food & beverages, biodefense), and region (North America, Europe, Asia Pacific and RoW). The report describes the major drivers, restraints, challenges, and opportunities pertaining to the biosensors market and forecasts the same till 2030. The report also consists of leadership mapping and analysis of all the companies included in the biosensor ecosystem. Key Benefits of Buying the Report The report will help the market leaders/new entrants in this market by providing information on the closest approximations of the revenue numbers for the overall biosensors market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities. The report provides insights on the following pointers: • Analysis of key drivers (emergence of nanotechnology-based biosensors, technological advancements, increasing use of biosensors to monitor glucose levels in individuals with diabetes, government initiatives to support diagnostics) restraints (reluctance to adopt new treatment practices, high costs of R&D), opportunities (emerging markets in developing countries, food & environmental monitoring applications, growth opportunities in wearables) and challenges (regulatory barriers and long certification & approval cycles) influencing the growth of the biosensors market • Product Development/Innovation: Detailed insights into upcoming technologies, research and development activities, and the latest product and service launches in the biosensors market • Market Development: Comprehensive information about lucrative markets – the report analyzes the biosensors market across varied regions • Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the biosensors market • Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players, such as Abbott Laboratories (US), F. Hoffmann-La Roche Ltd (Switzerland), Medtronic (Ireland), Bio-Rad Laboratories, Inc. (US), DuPont (US), Biosensors International Group, Ltd. (Singapore), Dexcom, Inc. (US), Masimo (US), Nova Biomedical (US), Universal Biosensors (Australia), and ACON Laboratories (US) in the biosensors market

目錄 Table of Contents

1 INTRODUCTION 23 1.1 STUDY OBJECTIVES 23 1.2 MARKET DEFINITION 23 1.2.1 INCLUSIONS AND EXCLUSIONS 24 1.3 STUDY SCOPE 24 1.3.1 MARKETS & REGIONS COVERED 24 1.3.2 YEARS CONSIDERED 25 1.3.3 CURRENCY CONSIDERED 25 1.3.4 UNITS CONSIDERED 25 1.4 STAKEHOLDERS 25 1.5 SUMMARY OF CHANGES 26 2 RESEARCH METHODOLOGY 27 2.1 RESEARCH DATA 27 2.1.1 SECONDARY DATA 28 2.1.1.1 List of major secondary sources 28 2.1.1.2 Key data from secondary sources 29 2.1.2 PRIMARY DATA 29 2.1.2.1 List of primary interview participants 29 2.1.2.2 Key data from primary sources 30 2.1.2.3 Breakdown of primaries 30 2.1.2.4 Key industry insights 31 2.1.3 SECONDARY AND PRIMARY RESEARCH 31 2.2 MARKET SIZE ESTIMATION METHODOLOGY 32 2.2.1 BOTTOM-UP APPROACH 32 2.2.2 TOP-DOWN APPROACH 33 2.2.2.1 Approach to derive market size (supply side) 33 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 35 2.4 RESEARCH ASSUMPTIONS 36 2.5 RESEARCH LIMITATIONS 36 2.6 RISK ANALYSIS 36 3 EXECUTIVE SUMMARY 37 4 PREMIUM INSIGHTS 42 4.1 ATTRACTIVE OPPORTUNITIES IN BIOSENSORS MARKET 42 4.2 BIOSENSORS MARKET FOR WEARABLE DEVICES, BY TYPE 42 4.3 BIOSENSORS MARKET IN NORTH AMERICA, BY COUNTRY AND BY PRODUCT 43 4.4 BIOSENSORS MARKET, BY COUNTRY 43 5 MARKET OVERVIEW 44 5.1 INTRODUCTION 44 5.2 MARKET DYNAMICS 44 5.2.1 DRIVERS 45 5.2.1.1 Emergence of nanotechnology-based biosensors 45 5.2.1.2 Technological advancements in recent years 46 5.2.1.3 Increasing use of biosensors to monitor glucose levels in individuals with diabetes 46 5.2.1.4 Supportive government initiatives for diagnostics 46 5.2.2 RESTRAINTS 47 5.2.2.1 Reluctance to adopt new treatment practices 47 5.2.2.2 High cost of biosensor R&D 47 5.2.3 OPPORTUNITIES 48 5.2.3.1 Emerging markets in developing countries 48 5.2.3.2 Rising food and environmental monitoring applications 48 5.2.3.3 Growth opportunities in wearables 49 5.2.4 CHALLENGES 49 5.2.4.1 Regulatory barriers and long certification & approval cycles 49 5.3 VALUE CHAIN ANALYSIS 50 5.4 ECOSYSTEM ANALYSIS 51 5.5 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 53 5.6 PRICING ANALYSIS 54 5.6.1 INDICATIVE SELLING PRICE TREND OF GLUCOSE MONITORING SYSTEMS, BY PRODUCT TYPE, 2025 54 5.6.2 INDICATIVE SELLING PRICE OF GLUCOSE MONITORING SYSTEMS, BY COMPANY, 2025 54 5.6.3 INDICATIVE SELLING PRICE TREND OF GLUCOSE MONITORING SYSTEMS, BY REGION 55 5.7 TECHNOLOGY ANALYSIS 56 5.7.1 KEY TECHNOLOGIES 56 5.7.1.1 Multiplexed Biosensors 56 5.7.2 COMPLEMENTARY TECHNOLOGIES 56 5.7.2.1 AI-Integrated Biosensing Platforms 56 5.7.3 ADJACENT TECHNOLOGIES 56 5.7.3.1 Drug Delivery Systems 56 5.8 CASE STUDY ANALYSIS 57 5.8.1 CASE STUDY 1: I-STAT SYSTEM HELPS PATIENTS AT ROCHDALE URGENT CARE CENTER 57 5.8.2 CASE STUDY 2: INTEGRATED HEALTH SOLUTION PROVIDED COST SAVINGS AND INCREASED EFFICIENCY 58 5.8.3 CASE STUDY 3: IMPROVING MOBILITY FOR PATIENTS AND REDUCING FALSE ALARMS FOR STAFF AT SUB-ACUTE CHILDREN’S HOSPITAL 58 5.8.4 CASE STUDY 4: ENABLING SEAMLESS DATA TRANSMISSION FROM PATIENT’S HOME 59 5.9 INVESTMENT AND FUNDING SCENARIO 59 5.10 IMPACT OF GEN AI/AI ON BIOSENSORS MARKET 60 5.11 PATENT ANALYSIS 61 5.12 TRADE ANALYSIS 64 5.13 PORTER’S FIVE FORCES ANALYSIS 67 5.13.1 INTENSITY OF COMPETITIVE RIVALRY 68 5.13.2 THREAT OF SUBSTITUTES 68 5.13.3 BARGAINING POWER OF BUYERS 68 5.13.4 BARGAINING POWER OF SUPPLIERS 68 5.13.5 THREAT OF NEW ENTRANTS 69 5.14 KEY STAKEHOLDERS AND BUYING CRITERIA 69 5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS 69 5.14.2 BUYING CRITERIA 70 5.15 KEY CONFERENCES AND EVENTS, 2025–2026 71 5.16 REGULATORY LANDSCAPE AND STANDARDS 72 5.16.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 72 5.16.2 STANDARDS 74 5.17 IMPACT OF 2025 US TARIFFS—BIOSENSORS MARKET 76 5.17.1 INTRODUCTION 76 5.17.2 KEY TARIFF RATES 76 5.17.3 PRICE IMPACT ANALYSIS 78 5.17.4 IMPACT ON COUNTRIES/REGIONS 78 5.17.4.1 US 78 5.17.4.2 Europe 78 5.17.4.3 Asia Pacific 79 5.17.5 IMPACT ON APPLICATIONS 79 5.17.5.1 Point of Care (PoC) 79 5.17.5.2 Home Diagnostics 79 6 BIOSENSORS MARKET, BY COMPONENT 80 6.1 INTRODUCTION 80 6.2 BIORECEPTOR MOLECULES 80 6.2.1 ANTIBODIES AND PROTEINS ARE ALSO USED AS BIORECEPTOR MOLECULES IN BIOSENSORS 80 6.3 BIOLOGICAL ELEMENTS 80 6.3.1 BIOLOGICAL ELEMENTS ARE MATERIALS RELATED TO BIOMOLECULES 80 6.4 TRANSDUCERS 81 6.4.1 TRANSDUCER CONVERTS BIOCHEMICAL ACTIVITIES INTO ELECTRICAL SIGNALS 81 7 BIOSENSORS MARKET, BY TYPE 82 7.1 INTRODUCTION 83 7.2 SENSOR PATCHES 84 7.2.1 WIDE-RANGE MONITORING OF VITAL SIGNS AND OTHER REQUIRED PARAMETERS 84 7.3 EMBEDDED DEVICES 84 7.3.1 BROAD-SPECTRUM DETECTION OF BIOLOGICAL ANALYTES, HIGH SUCCESS RATES IN MEDICAL LABS AND FOOD BIOANALYSES 84 8 BIOSENSORS MARKET, BY PRODUCT 85 8.1 INTRODUCTION 86 8.2 WEARABLE BIOSENSORS 87 8.2.1 WRISTWEAR 90 8.2.1.1 Real-time health and fitness tracking and monitoring 90 8.2.2 EYEWEAR 90 8.2.2.1 Smart glasses and smart lenses to have significant presence in market in coming years 90 8.2.3 FOOTWEAR 90 8.2.3.1 Help in monitoring kilometers run, calories burned, workout hours, blood pressure, and other fitness & health-related data 90 8.2.4 NECKWEAR 91 8.2.4.1 Trendy devices that can help monitor fitness and health 91 8.2.5 BODYWEAR 91 8.2.5.1 Have potential to equip clothes used for daily wear with smart capabilities, making detection of body movements possible 91 8.2.6 OTHER WEARABLE BIOSENSORS 91 8.3 NON-WEARABLE (POC) BIOSENSORS 91 8.3.1 REAL-TIME ON-SITE MONITORING OF PRODUCTION PROCESSES 91 9 BIOSENSORS MARKET, BY TECHNOLOGY 94 9.1 INTRODUCTION 95 9.2 ELECTROCHEMICAL BIOSENSORS 96 9.2.1 AMPEROMETRIC SENSORS 97 9.2.1.1 Blood glucose sensors 97 9.2.1.1.1 Suitable for medical devices for monitoring blood glucose 97 9.2.2 POTENTIOMETRIC SENSORS 97 9.2.2.1 Immunosensors 98 9.2.2.1.1 Label-free detection and quantification of immune complex 98 9.2.3 CONDUCTOMETRIC SENSORS 98 9.2.3.1 Studies in enzymatic reactions and practical applications such as drug and pollutant detection to propel market 98 9.3 OPTICAL BIOSENSORS 98 9.3.1 SPR BIOSENSORS 99 9.3.1.1 Measure interactions in real-time with high sensitivity and without needing labels 99 9.3.2 COLORIMETRIC BIOSENSORS 99 9.3.2.1 Used in various applications, such as detection and identification of virulence activities 99 9.3.3 FLUORESCENCE BIOSENSORS 100 9.3.3.1 Provide better sensitivities and specificities, as well as ease of labeling, while detection 100 9.4 PIEZOELECTRIC BIOSENSORS 100 9.4.1 ACOUSTIC BIOSENSORS 101 9.4.1.1 Monitor changes in physical properties of acoustic waves in response to measurand 101 9.4.2 MICROCANTILEVER BIOSENSORS 101 9.4.2.1 Promising tool for detecting biomolecular interactions with improved accuracy 101 9.5 THERMAL BIOSENSORS 102 9.5.1 STABILITY, NO NEED FOR FREQUENT RECALIBRATION, AND INSENSITIVITY TO OPTICAL AND ELECTROCHEMICAL PROPERTIES SUPPORT ADOPTION 102 9.6 NANOMECHANICAL BIOSENSORS 103 9.6.1 RAPID, SENSITIVE, AND SELECTIVE DETECTION OF BIOLOGICAL AND BIOCHEMICAL ENTITIES 103 10 BIOSENSORS MARKET, BY APPLICATION 104 10.1 INTRODUCTION 105 10.2 POC 106 10.2.1 GLUCOSE MONITORING 111 10.2.1.1 Rising prevalence of diabetes, advancements in self-monitoring, and growing awareness about PoC testing 111 10.2.2 CARDIAC MARKER DETECTION 111 10.2.2.1 Sedentary urban lifestyles driving prevalence of cardiovascular diseases 111 10.2.3 INFECTIOUS DISEASE DETECTION 111 10.2.3.1 Detection of toxins, bacteria, and viruses in physiological and environmental matrices 111 10.2.4 COAGULATION MONITORING 112 10.2.4.1 Growing use of anticoagulant therapy, coupled with adoption of self-testing kits for use at home 112 10.2.5 PREGNANCY TESTING 112 10.2.5.1 Growing preference of women for confidentiality and accessibility of test results 112 10.2.6 BLOOD GAS & ELECTROLYTE DETECTION 112 10.2.6.1 Growing global aging population to drive market 112 10.2.7 TUMOR/CANCER MARKER DETECTION 112 10.2.7.1 Increasing number of people suffering from cancer and growth in investments in cancer research 112 10.2.8 URINALYSIS TESTING 113 10.2.8.1 Rising number of urinary tract infections among individuals 113 10.2.9 CHOLESTEROL TESTING 113 10.2.9.1 Increasing prevalence of CVDs due to aging and obese population 113 10.3 HOME DIAGNOSTICS 113 10.3.1 GLUCOSE MONITORING 117 10.3.1.1 Growing preference for self-monitoring blood glucose devices 117 10.3.2 PREGNANCY TESTING 117 10.3.2.1 Need for portable and user-friendly pregnancy testing devices 117 10.3.3 CHOLESTEROL TESTING 118 10.3.3.1 Growth of diseases due to increased cholesterol levels in individuals 118 10.4 RESEARCH LABS 118 10.4.1 NEED FOR BIOSENSOR-BASED PRODUCT DEVELOPMENT FOR EARLY MONITORING OF DISEASES 118 10.5 ENVIRONMENTAL MONITORING 121 10.5.1 DETECTION OF CONTAMINANTS IN COMPLEX MATRICES WITH SEVERAL ADVANTAGES TO ENHANCE MARKET GROWTH 121 10.6 FOOD & BEVERAGES 125 10.6.1 BIOSENSORS USED FOR PATHOGEN DETECTION TO HELP MEET STRINGENT FOOD STANDARDS 125 10.7 BIODEFENSE 129 10.7.1 USE OF BIOSENSORS TO DETECT MICROBIAL PATHOGENS DURING BIOLOGICAL WARFARE 129 11 BIOSENSORS MARKET, BY REGION 133 11.1 INTRODUCTION 134 11.2 NORTH AMERICA 135 11.2.1 US 138 11.2.1.1 Availability of and interest in biosensor-based POC to drive market 138 11.2.2 CANADA 138 11.2.2.1 Increasing government support to propel market growth 138 11.2.3 MEXICO 138 11.2.3.1 Use of biosensors for detecting cardiovascular disorders to propel market growth in Mexico 138 11.3 EUROPE 139 11.3.1 GERMANY 142 11.3.1.1 Monitoring chronic diseases to escalate biosensors market growth 142 11.3.2 FRANCE 142 11.3.2.1 Technological advancements in healthcare systems to drive growth 142 11.3.3 UK 142 11.3.3.1 Rising cardiac diseases and aging population to drive market 142 11.3.4 ITALY 142 11.3.4.1 Growing private sector results in increasing demand for biosensors for various applications 142 11.3.5 REST OF EUROPE 143 11.4 ASIA PACIFIC 143 11.4.1 CHINA 145 11.4.1.1 Government initiatives for enhancing healthcare products and services to propel market growth 145 11.4.2 JAPAN 146 11.4.2.1 Increase in standard of living, rising health awareness, and surge in aging population to support market growth 146 11.4.3 INDIA 146 11.4.3.1 Growing population in India to escalate demand for biosensors in healthcare 146 11.4.4 REST OF ASIA PACIFIC 146 11.5 REST OF THE WORLD 147 11.5.1 SOUTH AMERICA 148 11.5.1.1 Growing environment-related concerns have boosted adoption of biosensors for environmental monitoring 148 11.5.2 MIDDLE EAST 148 11.5.2.1 Government and private support to drive adoption of POC testing kits will favor demand for biosensors 148 11.5.2.2 GCC Countries 149 11.5.2.2.1 Saudi Arabia 149 11.5.2.2.2 UAE 150 11.5.2.2.3 Rest of GCC Countries 150 11.5.2.3 Rest of Middle East 150 11.5.3 AFRICA 150 11.5.3.1 Increasing penetration in consumer electronics and medical devices 150 12 COMPETITIVE LANDSCAPE 151 12.1 OVERVIEW 151 12.2 STRATEGIES ADOPTED BY KEY PLAYERS, 2021–2024 151 12.3 REVENUE ANALYSIS, 2022–2024 152 12.4 MARKET SHARE ANALYSIS, 2024 153 12.5 COMPANY VALUATION AND FINANCIAL METRICS 156 12.6 BRAND/PRODUCT COMPARISON 157 12.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 157 12.7.1 STARS 158 12.7.2 EMERGING LEADERS 158 12.7.3 PERVASIVE PLAYERS 158 12.7.4 PARTICIPANTS 158 12.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 160 12.7.5.1 Company footprint 160 12.7.5.2 Region footprint 161 12.7.5.3 Product footprint 162 12.7.5.4 Type footprint 163 12.7.5.5 Technology footprint 164 12.7.5.6 Application footprint 165 12.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 166 12.8.1 PROGRESSIVE COMPANIES 166 12.8.2 RESPONSIVE COMPANIES 166 12.8.3 DYNAMIC COMPANIES 166 12.8.4 STARTING BLOCKS 166 12.8.5 COMPETITIVE BENCHMARKING OF STARTUPS/SMES 168 12.8.5.1 Detailed list of key startups/SMEs 168 12.8.5.2 Competitive benchmarking of key startups/SMEs 168 12.9 COMPETITIVE SCENARIO 169 12.9.1 PRODUCT LAUNCHES, APPROVALS, AND ENHANCEMENTS 169 12.9.2 DEALS 170 12.9.3 EXPANSIONS 172 13 COMPANY PROFILES 173 13.1 KEY PLAYERS 173 13.1.1 ABBOTT LABORATORIES 173 13.1.1.1 Business overview 173 13.1.1.2 Products/Solutions/Services offered 174 13.1.1.3 Recent developments 175 13.1.1.3.1 Product enhancements 175 13.1.1.3.2 Deals 176 13.1.1.4 MnM view 176 13.1.1.4.1 Key strengths/Right to win 176 13.1.1.4.2 Strategic choices 176 13.1.1.4.3 Weaknesses/Competitive threats 177 13.1.2 F. HOFFMANN-LA ROCHE LTD 178 13.1.2.1 Business overview 178 13.1.2.2 Products/Solutions/Services offered 179 13.1.2.3 Recent developments 180 13.1.2.3.1 Deals 180 13.1.2.4 MnM view 180 13.1.2.4.1 Key strengths/Right to win 180 13.1.2.4.2 Strategic choices 181 13.1.2.4.3 Weaknesses/Competitive threats 181 13.1.3 MEDTRONIC 182 13.1.3.1 Business overview 182 13.1.3.2 Products/Services/Solutions offered 183 13.1.3.3 Recent developments 184 13.1.3.3.1 Product approvals 184 13.1.3.3.2 Deals 184 13.1.3.4 MnM view 185 13.1.3.4.1 Key strengths/Right to win 185 13.1.3.4.2 Strategic choices 185 13.1.3.4.3 Weaknesses/Competitive threats 185 13.1.4 BIO-RAD LABORATORIES, INC. 186 13.1.4.1 Business overview 186 13.1.4.2 Products/Solutions/Services offered 187 13.1.4.3 MnM view 188 13.1.4.3.1 Key strengths/Right to win 188 13.1.4.3.2 Strategic choices 188 13.1.4.3.3 Weaknesses/Competitive threats 188 13.1.5 DUPONT 189 13.1.5.1 Business overview 189 13.1.5.2 Products/Solutions/Services offered 190 13.1.5.3 Recent developments 191 13.1.5.3.1 Deals 191 13.1.5.3.2 Expansion 191 13.1.5.4 MnM view 191 13.1.5.4.1 Key strengths/Right to win 191 13.1.5.4.2 Strategic choices 192 13.1.5.4.3 Weaknesses/Competitive threats 192 13.1.6 BIOSENSORS INTERNATIONAL GROUP, LTD. 193 13.1.6.1 Business overview 193 13.1.6.2 Products/Solutions/Services offered 193 13.1.6.3 Recent developments 194 13.1.6.3.1 Product approvals 194 13.1.7 CYTIVA 195 13.1.7.1 Business overview 195 13.1.7.2 Products/Solutions/Services offered 195 13.1.7.3 Recent developments 196 13.1.7.3.1 Deals 196 13.1.8 DEXCOM, INC. 197 13.1.8.1 Business overview 197 13.1.8.2 Products/Solutions/Services offered 198 13.1.8.3 Recent developments 198 13.1.8.3.1 Product launches 198 13.1.9 LIFESCAN IP HOLDINGS, LLC 199 13.1.9.1 Business overview 199 13.1.9.2 Products/Solutions/Services offered 199 13.1.10 MASIMO 200 13.1.10.1 Business overview 200 13.1.10.2 Products/Solutions/Services offered 201 13.1.10.3 Recent developments 201 13.1.10.3.1 Deals 201 13.1.11 NOVA BIOMEDICAL 202 13.1.11.1 Business overview 202 13.1.11.2 Products/Solutions/Services offered 202 13.1.11.3 Recent developments 203 13.1.11.3.1 Deals 204 13.1.12 UNIVERSAL BIOSENSORS 205 13.1.12.1 Business overview 205 13.1.12.2 Products/Solutions/Services offered 207 13.2 OTHER PLAYERS 208 13.2.1 ACON LABORATORIES 208 13.2.2 CONDUCTIVE TECHNOLOGIES 209 13.2.3 EASTPRINT INCORPORATED 210 13.2.4 IST AG 211 13.2.5 LIFESIGNALS 212 13.2.6 NEUROSKY 213 13.2.7 PINNACLE TECHNOLOGY 214 13.2.8 SD BIOSENSOR, INC. 215 13.2.9 VITALCONNECT 216 13.2.10 XSENSIO 217 13.2.11 ZIMMER AND PEACOCK 218 13.2.12 PARAGRAF LIMITED 219 13.2.13 DYNAMIC BIOSENSORS 219 13.2.14 LINEXENS 220 13.2.15 BIOLINQ INCORPORATED 220 14 APPENDIX 221 14.1 DISCUSSION GUIDE 221 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 224 14.3 CUSTOMIZATION OPTIONS 226 14.4 RELATED REPORTS 226 14.5 AUTHOR DETAILS 227

圖表清單 List of Tables & Figures

TABLE 1 BIOSENSORS MARKET: RESEARCH ASSUMPTIONS 36 TABLE 2 ROLE OF COMPANIES IN BIOSENSOR ECOSYSTEM 52 TABLE 3 INDICATIVE SELLING PRICE TREND OF GLUCOSE MONITORING SYSTEMS, BY PRODUCT TYPE (USD), 2025 54 TABLE 4 INDICATIVE SELLING PRICE OF GLUCOSE MONITORING SYSTEMS, BY COMPANY (USD), 2025 55 TABLE 5 INDICATIVE SELLING PRICE TREND OF GLUCOSE MONITORING SYSTEM, BY REGION, 2021–2024 (USD) 55 TABLE 6 BIOSENSORS MARKET: LIST OF MAJOR PATENTS 62 TABLE 7 IMPORT DATA FOR HS CODE 901890-COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 (USD THOUSAND) 65 TABLE 8 EXPORT DATA FOR HS CODE 901890-COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 (USD THOUSAND) 66 TABLE 9 BIOSENSORS MARKET: PORTER’S FIVE FORCES ANALYSIS 68 TABLE 10 BIOSENSORS MARKET: INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP 3 APPLICATIONS (%) 69 TABLE 11 BIOSENSORS MARKET: KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS 70 TABLE 12 BIOSENSORS MARKET: LIST OF KEY CONFERENCES AND EVENTS, 2025–2026 71 TABLE 13 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 73 TABLE 14 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 73 TABLE 15 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 74 TABLE 16 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 74 TABLE 17 NORTH AMERICA: SAFETY STANDARDS FOR BIOSENSORS 74 TABLE 18 EUROPE: SAFETY STANDARDS FOR BIOSENSORS 75 TABLE 19 ASIA PACIFIC: SAFETY STANDARDS FOR BIOSENSORS 75 TABLE 20 REST OF THE WORLD: SAFETY STANDARDS FOR BIOSENSORS 75 TABLE 21 US-ADJUSTED RECIPROCAL TARIFF RATES 76 TABLE 22 BIOSENSORS MARKET, BY TYPE, 2021–2024 (USD MILLION) 83 TABLE 23 BIOSENSORS MARKET, BY TYPE, 2025–2030 (USD MILLION) 83 TABLE 24 BIOSENSORS MARKET, BY PRODUCT, 2021–2024 (USD MILLION) 86 TABLE 25 BIOSENSORS MARKET, BY PRODUCT, 2025–2030 (USD MILLION) 86 TABLE 26 BIOSENSORS MARKET, BY PRODUCT, 2021–2024 (MILLION UNITS) 87 TABLE 27 BIOSENSORS MARKET, BY PRODUCT, 2025–2030 (MILLION UNITS) 87 TABLE 28 WEARABLE BIOSENSORS MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 88 TABLE 29 WEARABLE BIOSENSORS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 88 TABLE 30 WEARABLE BIOSENSORS MARKET, BY TECHNOLOGY, 2021–2024 (USD MILLION) 88 TABLE 31 WEARABLE BIOSENSORS MARKET, BY TECHNOLOGY, 2025–2030 (USD MILLION) 89 TABLE 32 WEARABLE BIOSENSORS MARKET, BY TYPE, 2021–2024 (USD MILLION) 89 TABLE 33 WEARABLE BIOSENSORS MARKET, BY TYPE, 2025–2030 (USD MILLION) 89 TABLE 34 NON-WEARABLE BIOSENSORS MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 92 TABLE 35 NON-WEARABLE BIOSENSORS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 92 TABLE 36 NON-WEARABLE BIOSENSORS MARKET, BY TECHNOLOGY, 2021–2024 (USD MILLION) 92 TABLE 37 NON-WEARABLE BIOSENSORS MARKET, BY TECHNOLOGY, 2025–2030 (USD MILLION) 93 TABLE 38 BIOSENSORS MARKET, BY TECHNOLOGY, 2021–2024 (USD MILLION) 95 TABLE 39 BIOSENSORS MARKET, BY TECHNOLOGY, 2025–2030 (USD MILLION) 95 TABLE 40 ELECTROCHEMICAL BIOSENSORS MARKET, BY PRODUCT, 2021–2024 (USD MILLION) 96 TABLE 41 ELECTROCHEMICAL BIOSENSORS MARKET, BY PRODUCT, 2025–2030 (USD MILLION) 96 TABLE 42 OPTICAL BIOSENSORS MARKET, BY PRODUCT, 2021–2024 (USD MILLION) 99 TABLE 43 OPTICAL BIOSENSORS MARKET, BY PRODUCT, 2025–2030 (USD MILLION) 99 TABLE 44 PIEZOELECTRIC BIOSENSORS MARKET, BY PRODUCT, 2021–2024 (USD MILLION) 100 TABLE 45 PIEZOELECTRIC BIOSENSORS MARKET, BY PRODUCT, 2025–2030 (USD MILLION) 101 TABLE 46 THERMAL BIOSENSORS MARKET, BY PRODUCT, 2021–2024 (USD MILLION) 102 TABLE 47 THERMAL BIOSENSORS MARKET, BY PRODUCT, 2025–2030 (USD MILLION) 102 TABLE 48 NANOMECHANICAL BIOSENSORS MARKET, BY PRODUCT, 2021–2024 (USD MILLION) 103 TABLE 49 NANOMECHANICAL BIOSENSORS MARKET, BY PRODUCT, 2025–2030 (USD MILLION) 103 TABLE 50 BIOSENSORS MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 105 TABLE 51 BIOSENSORS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 106 TABLE 52 BIOSENSORS MARKET FOR POC APPLICATIONS, BY TYPE, 2021–2024 (USD MILLION) 107 TABLE 53 BIOSENSORS MARKET FOR POC APPLICATIONS, BY TYPE, 2025–2030 (USD MILLION) 107 TABLE 54 BIOSENSORS MARKET FOR POC APPLICATIONS, BY PRODUCT, 2021–2024 (USD MILLION) 107 TABLE 55 BIOSENSORS MARKET FOR POC APPLICATIONS, BY PRODUCT, 2025–2030 (USD MILLION) 108 TABLE 56 BIOSENSORS MARKET FOR POC APPLICATIONS, BY REGION, 2021–2024 (USD MILLION) 108 TABLE 57 BIOSENSORS MARKET FOR POC APPLICATIONS, BY REGION, 2025–2030 (USD MILLION) 108 TABLE 58 NORTH AMERICA: BIOSENSORS MARKET FOR POC APPLICATIONS, BY COUNTRY, 2021–2024 (USD MILLION) 108 TABLE 59 NORTH AMERICA: BIOSENSORS MARKET FOR POC APPLICATIONS, BY COUNTRY, 2025–2030 (USD MILLION) 109 TABLE 60 EUROPE: BIOSENSORS MARKET FOR POC APPLICATIONS, BY COUNTRY, 2021–2024 (USD MILLION) 109 TABLE 61 EUROPE: BIOSENSORS MARKET FOR POC APPLICATIONS, BY COUNTRY, 2025–2030 (USD MILLION) 109 TABLE 62 ASIA PACIFIC: BIOSENSORS MARKET FOR POC APPLICATIONS, BY COUNTRY, 2021–2024 (USD MILLION) 110 TABLE 63 ASIA PACIFIC: BIOSENSORS MARKET FOR POC APPLICATIONS, BY COUNTRY, 2025–2030 (USD MILLION) 110 TABLE 64 REST OF THE WORLD: BIOSENSORS MARKET FOR POC APPLICATIONS, BY REGION, 2021–2024 (USD MILLION) 110 TABLE 65 REST OF THE WORLD: BIOSENSORS MARKET FOR POC APPLICATIONS, BY REGION, 2025–2030 (USD MILLION) 110 TABLE 66 BIOSENSORS MARKET FOR HOME DIAGNOSTICS APPLICATIONS, BY TYPE, 2021–2024 (USD MILLION) 113 TABLE 67 BIOSENSORS MARKET FOR HOME DIAGNOSTICS APPLICATIONS, BY TYPE, 2025–2030 (USD MILLION) 114 TABLE 68 BIOSENSORS MARKET FOR HOME DIAGNOSTICS APPLICATIONS, BY PRODUCT, 2021–2024 (USD MILLION) 114 TABLE 69 BIOSENSORS MARKET FOR HOME DIAGNOSTICS APPLICATIONS, BY PRODUCT, 2025–2030 (USD MILLION) 114 TABLE 70 BIOSENSORS MARKET FOR HOME DIAGNOSTICS APPLICATIONS, BY REGION, 2021–2024 (USD MILLION) 114 TABLE 71 BIOSENSORS MARKET FOR HOME DIAGNOSTICS APPLICATIONS, BY REGION, 2025–2030 (USD MILLION) 115 TABLE 72 NORTH AMERICA: BIOSENSORS MARKET FOR HOME DIAGNOSTICS APPLICATIONS, BY COUNTRY, 2021–2024 (USD MILLION) 115 TABLE 73 NORTH AMERICA: BIOSENSORS MARKET FOR HOME DIAGNOSTICS APPLICATIONS, BY COUNTRY, 2025–2030 (USD MILLION) 115 TABLE 74 EUROPE: BIOSENSORS MARKET FOR HOME DIAGNOSTICS APPLICATIONS, BY COUNTRY, 2021–2024 (USD MILLION) 115 TABLE 75 EUROPE: BIOSENSORS MARKET FOR HOME DIAGNOSTICS APPLICATIONS, BY COUNTRY, 2025–2030 (USD MILLION) 116 TABLE 76 ASIA PACIFIC: BIOSENSORS MARKET FOR HOME DIAGNOSTICS APPLICATIONS, BY COUNTRY, 2021–2024 (USD MILLION) 116 TABLE 77 ASIA PACIFIC: BIOSENSORS MARKET FOR HOME DIAGNOSTICS APPLICATIONS, BY COUNTRY, 2025–2030 (USD MILLION) 116 TABLE 78 REST OF THE WORLD: BIOSENSORS MARKET FOR HOME DIAGNOSTICS APPLICATIONS, BY REGION, 2021–2024 (USD MILLION) 117 TABLE 79 REST OF THE WORLD: BIOSENSORS MARKET FOR HOME DIAGNOSTICS APPLICATIONS, BY REGION, 2025–2030 (USD MILLION) 117 TABLE 80 BIOSENSORS MARKET FOR RESEARCH LAB APPLICATIONS, BY PRODUCT, 2021–2024 (USD MILLION) 118 TABLE 81 BIOSENSORS MARKET FOR RESEARCH LAB APPLICATIONS, BY PRODUCT, 2025–2030 (USD MILLION) 118 TABLE 82 BIOSENSORS MARKET FOR RESEARCH LAB APPLICATIONS, BY REGION, 2021–2024 (USD MILLION) 119 TABLE 83 BIOSENSORS MARKET FOR RESEARCH LAB APPLICATIONS, BY REGION, 2025–2030 (USD MILLION) 119 TABLE 84 NORTH AMERICA: BIOSENSORS MARKET FOR RESEARCH LAB APPLICATIONS, BY COUNTRY, 2021–2024 (USD MILLION) 119 TABLE 85 NORTH AMERICA: BIOSENSORS MARKET FOR RESEARCH LAB APPLICATIONS, BY COUNTRY, 2025–2030 (USD MILLION) 119 TABLE 86 EUROPE: BIOSENSORS MARKET FOR RESEARCH LAB APPLICATIONS, BY COUNTRY, 2021–2024 (USD MILLION) 120 TABLE 87 EUROPE: BIOSENSORS MARKET FOR RESEARCH LAB APPLICATIONS, BY COUNTRY, 2025–2030 (USD MILLION) 120 TABLE 88 ASIA PACIFIC: BIOSENSORS MARKET FOR RESEARCH LAB APPLICATIONS, BY COUNTRY, 2021–2024 (USD MILLION) 120 TABLE 89 ASIA PACIFIC: BIOSENSORS MARKET FOR RESEARCH LAB APPLICATIONS, BY COUNTRY, 2025–2030 (USD MILLION) 121 TABLE 90 REST OF THE WORLD: BIOSENSORS MARKET FOR RESEARCH LAB APPLICATIONS, BY REGION, 2021–2024 (USD MILLION) 121 TABLE 91 REST OF THE WORLD: BIOSENSORS MARKET FOR RESEARCH LAB APPLICATIONS, BY REGION, 2025–2030 (USD MILLION) 121 TABLE 92 BIOSENSORS MARKET FOR ENVIRONMENTAL MONITORING APPLICATIONS, BY PRODUCT, 2021–2024 (USD MILLION) 122 TABLE 93 BIOSENSORS MARKET FOR ENVIRONMENTAL MONITORING APPLICATIONS, BY PRODUCT, 2025–2030 (USD MILLION) 122 TABLE 94 BIOSENSORS MARKET FOR ENVIRONMENTAL MONITORING APPLICATIONS, BY REGION, 2021–2024 (USD MILLION) 122 TABLE 95 BIOSENSORS MARKET FOR ENVIRONMENTAL MONITORING APPLICATIONS, BY REGION, 2025–2030 (USD MILLION) 123 TABLE 96 NORTH AMERICA: BIOSENSORS MARKET FOR ENVIRONMENTAL MONITORING APPLICATIONS, BY COUNTRY, 2021–2024 (USD MILLION) 123 TABLE 97 NORTH AMERICA: BIOSENSORS MARKET FOR ENVIRONMENTAL MONITORING APPLICATIONS, BY COUNTRY, 2025–2030 (USD MILLION) 123 TABLE 98 EUROPE: BIOSENSORS MARKET FOR ENVIRONMENTAL MONITORING APPLICATIONS, BY COUNTRY, 2021–2024 (USD MILLION) 123 TABLE 99 EUROPE: BIOSENSORS MARKET FOR ENVIRONMENTAL MONITORING APPLICATIONS, BY COUNTRY, 2025–2030 (USD MILLION) 124 TABLE 100 ASIA PACIFIC: BIOSENSORS MARKET FOR ENVIRONMENTAL MONITORING APPLICATIONS, BY COUNTRY, 2021–2024 (USD MILLION) 124 TABLE 101 ASIA PACIFIC: BIOSENSORS MARKET FOR ENVIRONMENTAL MONITORING APPLICATIONS, BY COUNTRY, 2025–2030 (USD MILLION) 124 TABLE 102 REST OF THE WORLD: BIOSENSORS MARKET FOR ENVIRONMENTAL MONITORING APPLICATIONS, BY REGION, 2021–2024 (USD MILLION) 125 TABLE 103 REST OF THE WORLD: BIOSENSORS MARKET FOR ENVIRONMENTAL MONITORING APPLICATIONS, BY REGION, 2025–2030 (USD MILLION) 125 TABLE 104 BIOSENSORS MARKET FOR FOOD & BEVERAGE APPLICATIONS, BY PRODUCT, 2021–2024 (USD MILLION) 126 TABLE 105 BIOSENSORS MARKET FOR FOOD & BEVERAGE APPLICATIONS, BY PRODUCT, 2025–2030 (USD MILLION) 126 TABLE 106 BIOSENSORS MARKET FOR FOOD & BEVERAGE APPLICATIONS, BY REGION, 2021–2024 (USD MILLION) 126 TABLE 107 BIOSENSORS MARKET FOR FOOD & BEVERAGE APPLICATIONS, BY REGION, 2025–2030 (USD MILLION) 126 TABLE 108 NORTH AMERICA: BIOSENSORS MARKET FOR FOOD & BEVERAGE APPLICATIONS, BY COUNTRY, 2021–2024 (USD MILLION) 127 TABLE 109 NORTH AMERICA: BIOSENSORS MARKET FOR FOOD & BEVERAGE APPLICATIONS, BY COUNTRY, 2025–2030 (USD MILLION) 127 TABLE 110 EUROPE: BIOSENSORS MARKET FOR FOOD & BEVERAGE APPLICATIONS, BY COUNTRY, 2021–2024 (USD MILLION) 127 TABLE 111 EUROPE: BIOSENSORS MARKET FOR FOOD & BEVERAGE APPLICATIONS, BY COUNTRY, 2025–2030 (USD MILLION) 128 TABLE 112 ASIA PACIFIC: BIOSENSORS MARKET FOR FOOD & BEVERAGE APPLICATIONS, BY COUNTRY, 2021–2024 (USD MILLION) 128 TABLE 113 ASIA PACIFIC: BIOSENSORS MARKET FOR FOOD & BEVERAGE APPLICATIONS, BY COUNTRY, 2025–2030 (USD MILLION) 128 TABLE 114 REST OF THE WORLD: BIOSENSORS MARKET FOR FOOD & BEVERAGE APPLICATIONS, BY REGION, 2021–2024 (USD MILLION) 129 TABLE 115 REST OF THE WORLD: BIOSENSORS MARKET FOR FOOD & BEVERAGE APPLICATIONS, BY REGION, 2025–2030 (USD MILLION) 129 TABLE 116 BIOSENSORS MARKET FOR BIODEFENSE APPLICATIONS, BY PRODUCT, 2021–2024 (USD MILLION) 129 TABLE 117 BIOSENSORS MARKET FOR BIODEFENSE APPLICATIONS, BY PRODUCT, 2025–2030 (USD MILLION) 130 TABLE 118 BIOSENSORS MARKET FOR BIODEFENSE APPLICATIONS, BY REGION, 2021–2024 (USD MILLION) 130 TABLE 119 BIOSENSORS MARKET FOR BIODEFENSE APPLICATIONS, BY REGION, 2025–2030 (USD MILLION) 130 TABLE 120 NORTH AMERICA: BIOSENSORS MARKET FOR BIODEFENSE APPLICATIONS, BY COUNTRY, 2021–2024 (USD MILLION) 130 TABLE 121 NORTH AMERICA: BIOSENSORS MARKET FOR BIODEFENSE APPLICATIONS, BY COUNTRY, 2025–2030 (USD MILLION) 131 TABLE 122 EUROPE: BIOSENSORS MARKET FOR BIODEFENSE APPLICATIONS, BY COUNTRY, 2021–2024 (USD MILLION) 131 TABLE 123 EUROPE: BIOSENSORS MARKET FOR BIODEFENSE APPLICATIONS, BY COUNTRY, 2025–2030 (USD MILLION) 131 TABLE 124 ASIA PACIFIC: BIOSENSORS MARKET FOR BIODEFENSE APPLICATIONS, BY COUNTRY, 2021–2024 (USD MILLION) 132 TABLE 125 ASIA PACIFIC: BIOSENSORS MARKET FOR BIODEFENSE APPLICATIONS, BY COUNTRY, 2025–2030 (USD MILLION) 132 TABLE 126 REST OF THE WORLD: BIOSENSORS MARKET FOR BIODEFENSE APPLICATIONS, BY REGION, 2021–2024 (USD MILLION) 132 TABLE 127 REST OF THE WORLD: BIOSENSORS MARKET FOR BIODEFENSE APPLICATIONS, BY REGION, 2025–2030 (USD MILLION) 132 TABLE 128 BIOSENSORS MARKET, BY REGION, 2021–2024 (USD MILLION) 134 TABLE 129 BIOSENSORS MARKET, BY REGION, 2025–2030 (USD MILLION) 135 TABLE 130 NORTH AMERICA: BIOSENSORS MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 136 TABLE 131 NORTH AMERICA: BIOSENSORS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 137 TABLE 132 NORTH AMERICA: BIOSENSORS MARKET, BY COUNTRY, 2021–2024 (USD MILLION) 137 TABLE 133 NORTH AMERICA: BIOSENSORS MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 137 TABLE 134 EUROPE: BIOSENSORS MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 140 TABLE 135 EUROPE: BIOSENSORS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 141 TABLE 136 EUROPE: BIOSENSORS MARKET, BY COUNTRY, 2021–2024 (USD MILLION) 141 TABLE 137 EUROPE: BIOSENSORS MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 141 TABLE 138 ASIA PACIFIC: BIOSENSORS MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 144 TABLE 139 ASIA PACIFIC: BIOSENSORS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 145 TABLE 140 ASIA PACIFIC: BIOSENSORS MARKET, BY COUNTRY, 2021–2024 (USD MILLION) 145 TABLE 141 ASIA PACIFIC: BIOSENSORS MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 145 TABLE 142 REST OF THE WORLD: BIOSENSORS MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 147 TABLE 143 REST OF THE WORLD: BIOSENSORS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 147 TABLE 144 REST OF THE WORLD: BIOSENSORS MARKET, BY REGION, 2021–2024 (USD MILLION) 147 TABLE 145 REST OF THE WORLD: BIOSENSORS MARKET, BY REGION, 2025–2030 (USD MILLION) 148 TABLE 146 MIDDLE EAST: BIOSENSORS MARKET, BY REGION, 2021–2024 (USD MILLION) 148 TABLE 147 MIDDLE EAST: BIOSENSORS MARKET, BY REGION, 2025–2030 (USD MILLION) 149 TABLE 148 GCC COUNTRIES: BIOSENSORS MARKET, BY COUNTRY, 2021–2024 (USD MILLION) 149 TABLE 149 GCC COUNTRIES: BIOSENSORS MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 149 TABLE 150 BIOSENSORS MARKET: OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS, 2021–2024 151 TABLE 151 BIOSENSORS MARKET SHARE ANALYSIS, 2024 154 TABLE 152 BIOSENSORS MARKET: REGION FOOTPRINT 161 TABLE 153 BIOSENSORS MARKET: PRODUCT FOOTPRINT 162 TABLE 154 BIOSENSORS MARKET: TYPE FOOTPRINT 163 TABLE 155 BIOSENSORS MARKET: TECHNOLOGY FOOTPRINT 164 TABLE 156 BIOSENSORS MARKET: APPLICATION FOOTPRINT 165 TABLE 157 BIOSENSORS MARKET: LIST OF KEY START-UPS/SMES 168 TABLE 158 BIOSENSORS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 168 TABLE 159 BIOSENSORS MARKET: PRODUCT LAUNCHES, APPROVALS, AND ENHANCEMENTS, JANUARY 2021–MAY 2025 169 TABLE 160 BIOSENSORS MARKET: DEALS, JANUARY 2021–MAY 2025 170 TABLE 161 BIOSENSORS MARKET: EXPANSIONS, JANUARY 2021–MAY 2025 172 TABLE 162 ABBOTT LABORATORIES: COMPANY OVERVIEW 173 TABLE 163 ABBOTT LABORATORIES: PRODUCTS/SOLUTIONS/SERVICES OFFERED 174 TABLE 164 ABBOTT LABORATORIES: PRODUCT ENHANCEMENTS, JANUARY 2021–MAY 2025 175 TABLE 165 ABBOTT LABORATORIES: DEALS, JANUARY 2021–MAY 2025 176 TABLE 166 F. HOFFMANN-LA ROCHE LTD: COMPANY OVERVIEW 178 TABLE 167 F. HOFFMANN-LA ROCHE LTD: PRODUCTS/SOLUTIONS/SERVICES OFFERED 179 TABLE 168 F. HOFFMANN-LA ROCHE LTD: DEALS, JANUARY 2021–MAY 2025 180 TABLE 169 MEDTRONIC: COMPANY OVERVIEW 182 TABLE 170 MEDTRONIC: PRODUCTS/SOLUTIONS/SERVICES OFFERED 183 TABLE 171 MEDTRONIC: PRODUCT APPROVALS, JANUARY 2021–MAY 2025 184 TABLE 172 MEDTRONIC: DEALS, JANUARY 2021–MAY 2025 184 TABLE 173 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW 186 TABLE 174 BIO-RAD LABORATORIES, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 187 TABLE 175 DUPONT: COMPANY OVERVIEW 189 TABLE 176 DUPONT: PRODUCTS/SOLUTIONS/SERVICES OFFERED 190 TABLE 177 DUPONT: DEALS, JANUARY 2021–MAY 2025 191 TABLE 178 DUPONT: EXPANSIONS, JANUARY 2021–MAY 2025 191 TABLE 179 BIOSENSORS INTERNATIONAL GROUP, LTD.: COMPANY OVERVIEW 193 TABLE 180 BIOSENSORS INTERNATIONAL GROUP, LTD.: PRODUCTS/SOLUTIONS/ SERVICES OFFERED 193 TABLE 181 BIOSENSORS INTERNATIONAL GROUP, LTD.: PRODUCT APPROVALS, JANUARY 2021–MAY 2025 194 TABLE 182 CYTIVA: COMPANY OVERVIEW 195 TABLE 183 CYTIVA: PRODUCTS/SOLUTIONS/SERVICES OFFERED 195 TABLE 184 CYTIVA: DEALS, JANUARY 2021–MAY 2025 196 TABLE 185 DEXCOM, INC.: COMPANY OVERVIEW 197 TABLE 186 DEXCOM, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 198 TABLE 187 DEXCOM, INC.: PRODUCT LAUNCHES, JANUARY 2021–MAY 2025 198 TABLE 188 LIFESCAN IP HOLDINGS, LLC: COMPANY OVERVIEW 199 TABLE 189 LIFESCAN IP HOLDINGS, LLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED 199 TABLE 190 MASIMO: COMPANY OVERVIEW 200 TABLE 191 MASIMO: PRODUCTS/SOLUTIONS/SERVICES OFFERED 201 TABLE 192 MASIMO: DEALS, JANUARY 2021–MAY 2025 201 TABLE 193 NOVA BIOMEDICAL: COMPANY OVERVIEW 202 TABLE 194 NOVA BIOMEDICAL: PRODUCTS/SOLUTIONS/SERVICES OFFERED 202 TABLE 195 NOVA BIOMEDICAL: PRODUCT LAUNCHES, JANUARY 2021–MAY 2025 203 TABLE 196 NOVA BIOMEDICAL: DEALS, JANUARY 2021–MAY 2025 204 TABLE 197 UNIVERSAL BIOSENSORS: COMPANY OVERVIEW 205 TABLE 198 UNIVERSAL BIOSENSORS: PRODUCTS/SOLUTIONS/SERVICES OFFERED 207 FIGURE 1 BIOSENSORS MARKET SEGMENTATION 24 FIGURE 2 BIOSENSORS MARKET: RESEARCH DESIGN 27 FIGURE 3 BIOSENSORS MARKET: BOTTOM-UP APPROACH 33 FIGURE 4 BIOSENSORS MARKET SIZE ESTIMATION METHODOLOGY 34 FIGURE 5 BIOSENSORS MARKET: TOP-DOWN APPROACH 34 FIGURE 6 BIOSENSORS MARKET: DATA TRIANGULATION 35 FIGURE 7 BIOSENSOR MARKET FOR SENSOR PATCHES TO GROW AT HIGHER CAGR DURING FORECAST PERIOD 38 FIGURE 8 WEARABLE BIOSENSORS TO GROW AT HIGHER RATE DURING FORECAST PERIOD 39 FIGURE 9 ELECTROCHEMICAL TECHNOLOGY TO HOLD LARGEST SHARE IN 2030 39 FIGURE 10 POC APPLICATIONS TO HOLD LARGEST SHARE OF BIOSENSORS MARKET 40 FIGURE 11 BIOSENSORS MARKET IN ASIA PACIFIC TO GROW AT HIGHEST CAGR FROM 2025 TO 2030 41 FIGURE 12 RISING DEMAND FOR WEARABLE DEVICES TO DRIVE USE OF BIOSENSORS IN POC AND HOME DIAGNOSTIC APPLICATIONS 42 FIGURE 13 WRISTWEAR APPLICATION TO HOLD LARGEST SHARE OF WEARABLE BIOSENSORS MARKET THROUGHOUT FORECAST PERIOD 42 FIGURE 14 US AND NON-WEARABLE DEVICES TO HOLD LARGEST SHARE OF NORTH AMERICAN BIOSENSORS MARKET IN 2025 43 FIGURE 15 BIOSENSORS MARKET IN CHINA TO GROW AT HIGHEST CAGR FROM 2025 TO 2030 43 FIGURE 16 BIOSENSORS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 44 FIGURE 17 BIOSENSORS MARKET: DRIVERS AND THEIR IMPACT 45 FIGURE 18 BIOSENSORS MARKET: RESTRAINTS AND THEIR IMPACT 47 FIGURE 19 BIOSENSORS MARKET: OPPORTUNITIES AND THEIR IMPACT 48 FIGURE 20 BIOSENSORS MARKET: CHALLENGES AND THEIR IMPACT 49 FIGURE 21 BIOSENSORS MARKET: VALUE CHAIN ANALYSIS 50 FIGURE 22 BIOSENSORS MARKET: ECOSYSTEM 52 FIGURE 23 BIOSENSORS MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 53 FIGURE 24 AVERAGE SELLING PRICE OF GLUCOSE MONITORING SYSTEMS, BY COMPANY, 2025 (USD) 54 FIGURE 25 INDICATIVE SELLING PRICE TREND OF GLUCOSE MONITORING SYSTEM, BY REGION, 2021–2024 55 FIGURE 26 INVESTMENT AND FUNDING SCENARIO, 2023–2025 59 FIGURE 27 IMPACT OF GEN AI/AI ON BIOSENSORS MARKET 60 FIGURE 28 BIOSENSORS MARKET: PATENTS APPLIED AND GRANTED, 2014–2024 61 FIGURE 29 IMPORT DATA FOR PRODUCTS COVERED UNDER HS CODE 901890, BY COUNTRY, 2020–2025 (USD THOUSAND) 64 FIGURE 30 EXPORT DATA FOR PRODUCTS COVERED UNDER HS CODE 901890, BY COUNTRY, 2020–2024 (USD THOUSAND) 66 FIGURE 31 BIOSENSORS MARKET: PORTER’S FIVE FORCES ANALYSIS 67 FIGURE 32 BIOSENSORS MARKET: INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP 3 APPLICATIONS 69 FIGURE 33 BIOSENSORS MARKET: KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS 70 FIGURE 34 SENSOR PATCHES TO GROW AT HIGHER CAGR DURING FORECAST PERIOD 83 FIGURE 35 MARKET FOR WEARABLE BIOSENSORS TO GROW AT HIGHER RATE DURING FORECAST PERIOD 86 FIGURE 36 BIOSENSORS MARKET FOR ELECTROCHEMICAL TECHNOLOGY TO HOLD LARGEST SHARE IN 2030 95 FIGURE 37 POC APPLICATIONS HELD LARGEST MARKET SHARE OF BIOSENSORS MARKET IN 2025 105 FIGURE 38 NORTH AMERICA HOLDS LARGEST SHARE OF BIOSENSORS MARKET 134 FIGURE 39 NORTH AMERICA: BIOSENSORS MARKET SNAPSHOT 136 FIGURE 40 EUROPE: BIOSENSORS MARKET SNAPSHOT 140 FIGURE 41 ASIA PACIFIC: BIOSENSORS MARKET SNAPSHOT 144 FIGURE 42 REVENUE ANALYSIS OF TOP 5 PLAYERS, 2022–2024 152 FIGURE 43 MARKET SHARE ANALYSIS OF TOP 5 PLAYERS, 2024 153 FIGURE 44 COMPANY VALUATION 156 FIGURE 45 FINANCIAL METRICS (EV/EBITDA) 156 FIGURE 46 BIOSENSORS MARKET: BRAND/PRODUCT COMPARISON 157 FIGURE 47 BIOSENSORS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 159 FIGURE 48 BIOSENSORS MARKET: COMPANY FOOTPRINT 160 FIGURE 49 BIOSENSORS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 167 FIGURE 50 ABBOTT LABORATORIES: COMPANY SNAPSHOT 174 FIGURE 51 F. HOFFMANN-LA ROCHE LTD: COMPANY SNAPSHOT 179 FIGURE 52 MEDTRONIC: COMPANY SNAPSHOT 183 FIGURE 53 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT 187 FIGURE 54 DUPONT: COMPANY SNAPSHOT 190 FIGURE 55 DEXCOM, INC.: COMPANY SNAPSHOT 197 FIGURE 56 MASIMO: COMPANY SNAPSHOT 200 FIGURE 57 UNIVERSAL BIOSENSORS: COMPANY SNAPSHOT 206

Single User Licence	$4,950 USD
Multi User Licence	$6,650 USD
Corporate User Licence	$8,150 USD
Global User Licence	$10,000 USD

Biosensors Market by Type (Sensor Patch, Embedded Device), Product (Wearable, Non-Wearable), Wearable (Wristwear, Bodywear), Technology (Electrochemical, Optical, Piezoelectric, Thermal, Nanomechanical), Application and Region - Global Forecast to 2030

授權報價

報告摘要

同分類最新報告（電子與半導體）